贝那普利联合缬沙坦治疗早期糖尿病肾病的效果与安全性分析(2)
 |
| 第1页 |
参见附件。
[3] Macdonald-Wallis C，Lawlor DA，Palmer T，et al. Multivariate multilevel spline models for parallel growth processes：application to weight and mean arterial pressure in pregnancy [J]. Stat Med，2012，31(26)：3147-3164.
[4] Uno H，Ishikawa J，Hoshide S，et al. Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients [J]. Hypertens Res，2008，31(5)：887-896.
[5] Calabrese V，Mancuso C，Sapienza M，et al. Oxidative stress and cellular stress response in diabetic nephropathy [J]. Cell Stress Chaperones，2007，12(4)：299-306.
[6] Shamkhlova MS，Trubitsyna NP，Katsaia GV，et al. The angiotensin Ⅱ inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy [J]. Ter Arkh，2008，80(1)：49-52.
[7] Jia ZH，Liu ZH，Zheng JM，et al. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice [J]. Exp Clin Endocrinol Diabetes，2007，115(9)：571-576.
[8] Dong YF，Liu L，Lai ZF，et al. Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice [J]. J Hypertens，2010，28(7)：1554-1565.
(收稿日期：2013-01-10 本文编辑：张瑜杰)
您现在查看是摘要介绍页，详见PDF附件。